David Segal
Non-Independent Director
Phosphagenics
Australia
Biography
Mr Segal joined the Board in May 2016. He was Investor Relations Manager at Phosphagenics from 2011 to 2015. He worked in stockbroking for over 30 years, including setting up, raising capital for and running Trent Securities which was absorbed into Shaw Stockbroking in 1992. Mr Segal has been a shareholder with Phosphagenics since 1999 when it was known as Vital Capital and has a close rapport with many shareholders whom he engaged with in his role as Investor Relations Manager or as an investment adviser at Shaw Stockbroking. He has a law/commerce degree from Melbourne University and is a Graduate of the Australian Institute of Company Directors.
Research Interest
Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology Pharmaceutical Technology Pharmaceutical Manufacturing Pharmaceutical Engineering Drug Delivery Technologies Medical Devices Drug Regulatory Affairs Pharmaceutical Management
